(1)
Wollenberg, A.; de Bruin-Weller, M.; Thyssen, J. P.; Beck, L. A.; Simpson, E. L.; Imafuku, S.; Boguniewicz, M.; Kurbasic, A.; Soldbro, L.; Strange Vest, N.; Arlert, P.; Paller, A. S. Conjunctivitis in Adolescent Patients Aged 12–17 With Moderate-to-Severe Atopic Dermatitis Treated With Tralokinumab up to Week 52: Results from the Phase 3 ECZTRA 6 Trial. J of Skin 2022, 6, s75.